The World's Most Demonized Anti-inflammatory — Key Takeaways
Substack
The World's Most Demonized Anti-inflammatory
Dalton (Analyze & Optimize)Mar 16, 2026
Read the originalNicotine patches (5–15 mg/day) reduced ulcerative colitis symptoms in human trials and cut inflammatory response to endotoxin at 7 mg, acting via nicotinic acetylcholine receptors that suppress NFκB and STAT3 signaling.
Key takeaways
Nicotine is context-dependent — pro-inflammatory in some conditions
Nicotine is context-dependent — pro-inflammatory in some conditions
- Nicotine can be pro-inflammatory depending on the condition and disease stage; it is not a universal anti-inflammatory.
- Side effects include restlessness and rapid heart rate; addiction risk is real. Patch preferred over smoking.
Nicotine (5–15 mg/day) improves ulcerative colitis symptoms in humans
Nicotine (5–15 mg/day) improves ulcerative colitis symptoms in humans
- Human trials using 5–15 mg/day nicotine showed improvements in multiple gut inflammation markers in UC patients.
- 7 mg nicotine patch also reduced inflammatory response to endotoxin in a separate human study.
Nicotine suppresses MS progression via NFκB/STAT3 inhibition in animal models
Nicotine suppresses MS progression via NFκB/STAT3 inhibition in animal models
- Nicotine-treated MS animals showed improved myelination, reduced brain lesions, and lower ROS/inflammation scores.
- Mechanism: nicotinic acetylcholine receptors on immune cells inhibit NFκB and STAT3, shifting T cells toward regulatory (anti-autoimmune) status.
This Dig holds the full set of insights, 4 flashcards, and 2 quotes — free in Homestake.
Unlock this Dig freeFree forever · No credit card required
In this piece
- Nicotine's Anti-Inflammatory Effects: Epidemiological Evidence
- Nicotine and Multiple Sclerosis: Experimental Evidence
- Nicotine's Effects on Allergies and Myocarditis
- Mechanism: Nicotinic Acetylcholine Receptors and Immune Signaling
This page is a partial, transformative summary produced by Homestake. All rights to the original content remain with its creator — please support them at the source link above.
